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Abstract
Previous studies show that acute choline deficiency (CD) triggers apoptosis in cultured rat
hepatocytes (CWSV-1 cells). We demonstrate that prolonged EGF stimulation (10 ng/mL x 48 hrs)
restores cell proliferation, as assessed by BrdU labeling, and protects cells from CD-induced
apoptosis, as assessed by TUNEL labeling and cleavage of poly(ADP-ribose) polymerase. However,
EGF rescue was not accompanied by restoration of depleted intracellular concentrations of choline,
glycerphosphocholine, phosphocholine, or phosphatidylcholine. In contrast, we show that EGF
stimulation blocks apoptosis by restoring mitochondrial membrane potential (ΔΨm), as determined
using the potential-sensitive dye chloromethyl-X-rosamine, and by preventing the release and nuclear
localization of cytochrome c. We investigated whether EGF rescue involves EGF receptor
phosphorylation and activation of the down-stream cell survival factor Akt. Compared to cells in
control medium (CT, 70 μmol choline x 48hrs), cells in CD medium (5 μmol choline) were less
sensitive to EGF-induced (0–300 ng/mL x 5 min) receptor tyrosine phosphorylation. Compared to
cells in CT medium, cells in CD medium treated with EGF (10 ng/mL x 5 min) exhibited higher
levels of phosphatidylinositol 3-kinase (PI3K)-dependent phosphorylation of AktSer473.
Inactivation of PI3K was sufficient to block EGF-stimulated activation of Akt, restoration of
mitochondrial ΔΨm, and prevention of cytochrome c release. These studies indicate that stimulation
with EGF activates a cell survival response against CD-apoptosis by restoring mitochondrial
membrane potential and preventing cytochrome c release and nuclear translocation which are
mediated by activation of Akt in hepatocytes.
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Introduction
Previous studies have emphasized the role for choline, an essential nutrient [1], in normal cell
function, including synthesis of membrane phosphatidylcholine (PtdCho), methyl group-
donation, and DNA synthesis [2–4]. An intriguing feature of choline metabolism is that acute
choline deficiency (CD) results in dysregulation of liver cell proliferation and decreased cell
survival [5–9], whereas prolonged CD results in acquisition of resistance to apoptosis and in
malignant transformation [10,11]. Thus, although CD is associated with diverse
pathophysiological events in liver, the precise role for choline metabolites in the intracellular
signaling pathways mediating these responses is not clear.
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Membrane receptors and membrane derived signaling intermediates have been implicated in
the response to CD. In rats fed a choline deficient diet, liver cells accumulated 1,2-sn-
diacylglycerol, and exhibited prolonged activation of protein kinase C (PKC) [12]. Activation
of PKC downstream of CD is important for an array of cellular processes, including modulation
of cytoskeletal organization and cell motility [13], as well as for transduction of growth factor-
mediated inhibitory (e.g., transforming growth factor beta) [14] and stimulatory cell signaling
(e.g., epidermal growth factor, EGF) [15]. In animals made choline deficient, liver cells
expressed fewer membrane receptors for epidermal growth factor (EGF) [16]. Although
decreased cell survival in cells exposed to acute CD is accompanied by the loss of mitochondrial
membrane potential (ΔΨm) [9], the interrelationship between mitochondrial function and EGF
in CD-apoptosis is not well understood. In this study, we have determined that CD is a regulator
of the EGF signaling pathway in CWSV-1 rat hepatocytes and that stimulation with EGF
receptor activates a cell survival response in these cells that is mediated by activation of Akt




CWSV-1 cells originated from normal male F344 rat hepatocytes, and are routinely grown in
serum-free medium [17] and express liver-specific proteins. Transfection of cells with SV40
large T-antigen inactivates p53 function, and CWSV-1 cells do not respond to γ-radiation, a
p53-dependent apoptotic trigger [18]. CWSV-1 cells were maintained in RPCD defined
medium: RPMI 1640 medium (Atlanta Biologicals, Norcross, GA) containing 11.5 μmol
bovine serum albumin (Sigma Chemical, St. Louis, MO), 2 mmol L-glutamine (Sigma), 20
μmol oleate (Sigma), 7.2 μmol linoleate (Sigma), 67 μmol ethanolamine (Sigma), 1.27 μmol
transferrin (Sigma), 10.4 nmol insulin (Sigma), 1 μmol dexamethasone (Sigma), 10 nmol
glucagon (Sigma), 15 mmol HEPES, pH 7.4 (Sigma), trace metals (Sigma), 100 μg/mL
penicillin (Gibco-BRL, Grand Island, NY), 100 μg/mL streptomycin and choline chloride as
indicated.
Assessment of Apoptosis
For morphological assessment of apoptosis, cells were seeded at 2.2 x 104 cells/cm2 in 6-well
multi-well plates in 70 μM choline-supplemented RPCD medium for 4 days before rinsing
with phosphate-buffered saline (PBS) and switching them to fresh, control (CT; 70 μmol
choline), or choline-deficient (CD; 5 μmol choline) RPCD medium for an additional 2 days as
described in figures. To investigate the role of EGF receptor function in apoptosis, cells were
maintained for 2 days in CT or CD medium with or without EGF (human recombinant, >97%
purity by SDS-PAGE; Sigma Chemical Co., St. Louis, MO). Cells with classical morphological
features of apoptosis were detected in hematoxylin stained plates as described previously [5].
The presence of apoptosis was confirmed by Tdt-mediated dUTP nick end labeling (TUNEL)
assay [5,11], and by cleavage of poly(ADP-ribose)polymerase (PARP) (6).
Assessment of Cell Proliferation
Cells grown in LabTek® chamber slides on day 2 of treatment with experimental media were
incubated with 100 μmol 5-bromo-2′-deoxyuridine (BrdU) (Sigma) as described previously
[19] and then fixed in ice-cold 70 percent ethanol. Sites of BrdU incorporation were visualized
using an indirect streptavidin-peroxidase immunocytochemical method and a commercially
available kit (Zymed, South San Francisco, CA), followed by counterstaining with Gill
hematoxylin. The BrdU labeling index was determined by counting at least 200 cells in 3
replicates per experiment.
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Cell samples (5–6 x 106 cells per sample) were harvested and suspended in PBS following
treatment as described above. DNA content was measured as a basis for normalization using
a previously described fluorometric method [20]. For choline and related metabolites, an
aliquot of cell suspension was extracted [21] and [2H-methyl]-labeled internal standard of each
metabolite was added to permit correction for recovery. After separating the extracts into
organic and aqueous phases, both hydrophilic choline metabolites (betaine, choline,
glycerophosphocholine, and phosphocholine), and hydrophobic metabolites
(phosphatidylcholine and sphingomyelin) were quantified using liquid chromatography-
electrospray ionization-isotope dilution mass spectrometry [22].
Immunoblotting
CWSV-1 cells in the log phase of growth were treated with agonists for the indicated times,
washed x2 in phosphate-buffered saline containing 1 mmol vanadate (PBS-V), then placed
immediately in lysis buffer (1% NP40, 20 mmol Tris-HCl (pH 8.0), 150 mmol NaCl, 1 mmol
EDTA, 0.1% NaN3, 2% SDS, 0.1 mmol Na3VO4, 1 mmol PMSF, 10 μg/mL aprotinin, 1 μmol
pepstatin, 16.4 μg/mL leupeptin, and 10% glycerol). Lysates were heated at 95°C and protein
concentrations determined, with BSA used to generate a standard curve, prior to adding 100
mmol DTT tracking dye. Samples were heated again for 5 min at 95°C, and the proteins
separated using 8–10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
electrotransferred onto nitrocellulose membranes (Schleicher & Schuell, Keene, NH). The
membranes were incubated in blocking buffer containing 1% BSA for blotting with anti-
phosphotyrosine antibodies. Membranes were subsequently incubated in RC20 antibody
(detects EGF receptor tyrosine; Transduction Laboratories, Lexington, KY). Immunoblots
were developed using a horseradish peroxidase conjugated secondary antibody and an ECL
method (Amersham Pharmacia, Piscataway, NJ).
Mitochondrial function
We showed that CD disrupts mitochondrial transmembrane potential (ΔΨm), measured with
the potential-sensitive dye JC-1, in CWSV-1 cells prior to the appearance of apoptosis [9]. To
determine whether EGF-rescue of CD-apoptosis could involve restoration of mitochondrial
function, we measured ΔΨm using the potential-sensitive dye chloromethyl-X-Rosamine
(CMX-Ros; 200 nmol; Molecular Probes, Eugene, OR) [23]. CMX-Ros, unlike JC-1, has the
advantage that changes in ΔΨm can be stabilized by formalin fixation for measurement at later
time intervals. CMX-Ros (200 nmol) was added to the cell cultures for a 30 min incubation
period at 37°C. The incubation was stopped by washes with PBS followed by fixation with
4% formaldehyde in PBS. 4′,6-Diamidino-2-phenylindole (DAPI), 0.1 μg/mL, for 20 min was
used to counterstain nuclear DNA. Cells were mounted using GelMount® and a No. 1 thickness
coverglass. Fluorescence images were obtained with a Nikon FX microscope using 595/615-
nm filters. The levels of CMX-Ros were determined using an unbiased image analysis method
and Scion Image as described previously [24].
Release of cytochrome c
CWSV-1 cells were grown on glass chamber slides, switched for an additional 48 hr to control
(70 μmol choline) or choline deficient medium (5 μM choline) with or without EGF (10 ng/
mL). The cells were then fixed in 4% formaldehyde in PBS, washed three times with PBS
containing 0.1% Tween 20 (PBS-T), and blocked for 1 hr with 5% normal goat serum. After
incubating with rabbit anticytochrome c (clone H-104, Santa Cruz Biotechnology, Santa Cruz,
CA) at a dilution of 1:500 in 5% blocking serum in PBS-T for 1 hr at room temperature, the
cells were washed three times with PBS-T, and then incubated with goat antirabbit Alexa
Fluor® 546 conjugate secondary antibody at a dilution of 1:1000 in 5% blocking serum in
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PBS-T for 1 hr. The cells were washed three times with PBS, and coverslips were mounted
onto slides with aqueous mounting medium. Fluorescence was visualized using a Zeiss LSM
5 Pascal confocal microscope equipped with a band-pass filter (excitation 535 nm, emission
570 nm) and fluorescent images were captured using Scion Image as described previously
[24]. For immunoblotting analysis of cytochrome c release, total cell lysates were prepared as
described below, loaded onto SDS-polyacrylamide gels and Western blotted for cytochrome
c release using rabbit anticytochrome c (Santa Cruz Biotechnology) and an enhanced
chemiluminescence method (Amersham Pharmacia Biotechnology, Piscataway, NJ).
EGF receptor autophosphorylation
CWSV-1 cells maintained for 48hr in CT or CD medium were treated with EGF (0–300 ng/
mL x 5 min), cell lysates were prepared, and the levels of tyrosine phosphorylation of EGF
(EGF pTyr) were assayed by immunoblotting with anti-phosphotyrosine antibody (RC-20,
Transduction Lab.) and quantified by densitometry. The band intensity of the heat shock protein
90 kDa product (hsp 90) was measured as a basis for normalization of the corresponding 170
kDa EGF receptor tyrosine band intensities in CT and CD samples.
PI3 kinase and Akt
Cells in CT or CD medium were treated with EGF (10 ng/mL x 48 hr) in the presence or absence
of LY294002 (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; Sigma), a specific
inhibitor of phosphatidylinositol 3-kinase (PI3K). Proteins in whole cell lysates were subjected
to SDS-PAGE and transferred to nitrocellulose membranes as described above. The blots were
probed with the following antibodies: antiphospho-Akt (Ser473) and total Akt, antiphospho-
FKHR (Ser256) and total FKHR, anti-AFX, and antiphospho-BAD (Ser136) (all from Cell
Signaling Technology, Beverly, MA). Immunoblots were developed as described above.
Statistical analysis
Statistical differences among group means for apoptosis were assessed using Student’s t test.
Analysis of variance and appropriate multiple comparisons procedures were used to determine
statistical significance among group means for choline and its metabolites, mitochondrial
transmembrane potential (ΔΨm), and for cell proliferation (BrdU labeling) (JMP Version 2,
SAS Institute, Cary, NC).
Results
EGF and Choline Deficiency Apoptosis
Previous evidence demonstrated that feeding an extremely methyl-deficient diet (i.e., choline,
methionine, folic acid and vitamin B12 deficient) to rats decreased EGF receptor mRNA
expression and increased cell death in their livers, although the mode of cell death was not
determined [25]. This evidence, coupled with later studies showing that feeding a diet deficient
in choline alone is sufficient to induce apoptosis in rat liver hepatocytes [26], led us to
investigate the role of EGF in CD apoptosis in CWSV-1 rat hepatocytes. Cells cultured in low
choline-containing medium (5 μmol choline) exhibited increased levels of the 89 kDa PARP-
cleaved product (Figure 1), and a nearly 8-fold increased rate of apoptosis (apoptotic
morphology, TUNEL (+)) compared to cells in control medium (CT, 70 μmol choline) (Figure
1). In contrast, the rate of CD-apoptosis and the level of PARP cleavage product were
dramatically reduced when cells were grown in CD medium containing EGF (10 ng/mL x 48
hrs).
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EGF and Mitochondrial Function
CWSV-1 cells switched to CD medium for 2 days exhibited a significant reduction in the
incorporation of CMX-Ros, consistent with disruption in ΔΨm. Loss of this transmembrane
potential was prevented in cells that had been treated for 2 days with EGF (10 ng/ml) in the
presence of CD (Figure 2). To further investigate the role of mitochondrial function in CD-
apoptosis, we localized cytochrome c in CWSV-1 cells in control and CD cells that had been
treated for 2 days with EGF (10 ng/mL) (Figure 3A–D). For cells in control medium,
cytochrome c staining was localized in a punctate perinuclear pattern (Figure 3A), consistent
with mitochondrial localization of cytochrome c, and was unaffected by the addition of EGF
(Figure 3B). In contrast, CD cells exhibited a diffuse pattern of cytochrome c staining
throughout the cytoplasm and nucleus (Figure 3C), consistent with mitochondrial release of
cytochrome c that was translocated to the nucleus. Stimulation of CD cells with EGF restored
cytochrome c to a punctate and perinuclear staining pattern (Figure 3D), consistent with
prevention of cytochrome c release from mitochondria. Western blotting for the presence of
cytochrome c in total cell lysates was performed. Cytochrome c was detected in similar amounts
independent of the amount of choline or EGF in the medium (Figure 3E).
EGF and Choline Metabolite
We measured the levels of choline metabolites in control and CD cells that had been treated
for 2 days with EGF (10 ng/mL). Compared to controls, cells maintained for 2 days in CD
medium in the absence of EGF had approximately 67%, 90%, and 14% less choline,
phosphocholine (PCho), and PtdCho, respectively, which was not restored by the addition of
EGF to the medium (Table 1).
EGF and Inhibition of Cell Proliferation by CD
One of the key choline metabolites involved in the regulation of cell proliferation is PCho. It
is a mitogenic factor for some types of cells [27]. Since EGF did not restore PCho levels in
CD cells (Table 1), we examined whether DNA synthetic activity was modulated during CD
and whether the depleted levels of PCho reduced the ability of EGF to stimulate DNA synthetic
activity in CD cells, as determined by the incorporation of BrdU. As expected, CD treatment
alone for 48 hr (Figure 4) reduced DNA synthetic activity. Restoration of DNA synthetic
activity was observed when CD CWSV-1 cells were treated with EGF, even though the level
of PCho remained at 10% of control levels (Table 1).
CD Alters EGF Receptor Phosphorylation
Ligand binding with EGFR results in autophosphorylation of intracellular EGFR tyrosine
residues which regulate multiple biological processes. Since EGF stimulated cell proliferation
and inhibited apoptosis in CD-cells, we examined the effects of EGF on EGFR tyrosine
phosphorylation. Compared to CWSV-1 cells in control medium (70 μmol choline), cells in
CD medium exhibited decreased sensitivity to EGF-induced receptor tyrosine phosphorylation
when band intensities were normalized to hsp90 kDa protein loading controls (Figure 5). Thus,
treatment with EGF increased EGF pTyr by 1.8-fold in CWSV-1 cells maintained in CT
medium compared to 1.1-fold in cells in grown in CD medium. This is consistent with EGF
receptor-mediated activation of downstream signal transduction important for proliferation and
survival in CD cells.
Akt activation, forkhead transcription factors, and EGF protection
Activation of the Akt pathway by EGF is regulated by catalytically active PI3K, resulting in
phosphorylation of Akt on Ser473. The expression of AktSer473 was increased by EGF (10ng/
mL x 5 min) in both CT and CD cells (Figure 6), and was undetectable in cells treated with
EGF in the presence of LY294002 (Figure 6). PI3K signaling and AktSer473 are involved in
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phosphorylation and inactivation of Forkhead transcription factors, thereby regulating cell
cycle entry and apoptosis in some types of cells. However, CD and CT cells maintained in the
absence or presence of EGF showed no detectable differences in the levels of activated or
inactivated Forkheads AFX or FKHR (i.e., AFXSer193, FKHRSer256) (Figure 7), or in the
levels of phosphorylated (inactivated) BadSer136 (data not shown). Importantly, inactivation
of PI3K using LY294002 blocked EGF restoration of mitochondrial cytochrome c (Figure 3)
and ΔΨm (data not shown). Taken together, these results indicated that stimulation with EGF
activates a cell survival response that is mediated, in part, by PI3K-dependent inhibition of
CD-induced early pro-apoptotic mitochondrial alterations (Figure 8).
Discussion
Previous studies showed that, when CWSV-1 cells are deprived of extracellular choline, they
become depleted of intracellular choline, PCho, and PtdCho, and undergo mitotic growth
inhibition and apoptosis [5,7,11]. PtdCho, a phospholipid generated from the CDP-choline
pathway, and from the phosphatidylethanolamine N-methyltransferase (PEMT) pathway,
plays a significant role in membrane function [28] and is a source of important intracellular
signaling intermediates (e.g., diacylglycerol) [12] and bioactive lipids (e.g., arachidonic acid,
platelet activating factor) [29]. In addition to affecting intracellular signaling, earlier studies
suggested choline metabolism could influence transmembrane signal transduction. In fact,
feeding rats an extremely methyl-deficient diet decreased the expression of EGF receptor
mRNA [16], suggesting a link between choline availability and EGF receptor-mediated
signaling. The present study shows that CD cells compared to controls are less sensitive to
EGF-stimulation of EGF receptor tyrosine phosphorylation. EGF receptor tyrosine
phosphorylation is needed for ligand-stimulation of downstream signaling pathways that
regulate cell proliferation and survival [30]. We demonstrate that stimulation with EGF
activates a PI3 kinase-dependent cell survival response that results in prevention of apoptosis
and restoration of DNA synthetic activity in CD cells.
Studies show that cell proliferation and survival are coordinated with metabolism of choline.
Thus, in lymphocytes, the rate of synthesis of PCho was higher in proliferating cells than in
growth arrested cells [31] or in cells undergoing apoptosis [32], consistent with the effects of
CD on CWSV-1 cells. Competitive interference with diacylglycerol for CTP:cholinephosphate
cytidylyltransferase (CT), the final enzyme in the biosynthesis of PtdCho, or mutational down
regulation of the CT enzyme, impairs mitotic cell division and induces apoptosis [33,34].
Importantly, exogenous PtdCho, lysophosphatidylcholine, or PCho, but not expression of
PEMT or exogenous methyl-group donors, were able to restore DNA synthetic activity and to
rescue primary neuronal cells, fibroblasts, or CWSV-1 hepatocytes from apoptosis [7,33,35,
36].
Links have been identified between EGF and choline metabolism in some types of cells. In
lung and HeLa cells, EGF increased the activity of choline kinase [37] and CT [38], thereby
increasing the rate of synthesis of PtdCho. In HeLa cells, increased expression of CT under
the control of a tetracycline-responsive promoter prevented apoptosis induced by ET-18-OCH3
[27], a known trigger of apoptosis in CWSV-1 cells [9]. In T51B rat liver cells, EGF stimulation
of DNA synthesis was preceded by a slow increase in the activity of phospholipase D (PLD)
and the level of free choline [39]. EGF receptor tyrosine kinase activity is required for the
activation of PLD [40]. In the present studies, we show that continuous treatment of cells with
EGF at the time they are switched to CD medium rescues them from CD-apoptosis and restores
DNA synthetic activity without restoring PCho or PtdCho levels. This suggests the
involvement of one or more alternative pathways for effecting cell survival despite inadequate
levels of choline.
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Previously we demonstrated that acute CD increased apoptosis and inhibited mitotic cell
division in CWSV-1 cells, as well as in whole rat liver [26,41]. Recent studies showed that
non-hepatocyte epithelial cells deprived of EGF [42] or prevented from activating the EGF
receptor tyrosine kinase underwent cell cycle arrest that was reversed by the addition of EGF
[43]. Consistent with these studies, EGF stimulated DNA synthetic activity in hepatocytes
maintained in adequate levels of choline[44]. Here we show that stimulation of hepatocytes
with EGF at the time that they are switched to CD medium, increases EGF receptor tyrosine
phosphorylation, resulting in PI3 kinase-dependent activation of Akt and restoration of DNA
synthetic activity. These findings are consistent with previous studies showing that activation
of the PI3 kinase pathway, and not the MAPK pathway, is necessary and sufficient to explain
the induction of DNA synthesis by EGF in primary hepatocytes [45].
In addition to inhibition of DNA synthesis, CD in the absence of EGF resulted in loss of
mitochondrial ΔΨm, consistent with earlier studies showing that TGFβ1, a mediator of CD-
apoptosis, caused dissipation of ΔΨm [46] and increased generation of reactive oxygen species
from both mitochondrial and microsomal compartments [47]. We now show that, in addition
to dissipation of ΔΨm, CD causes mitochondrial release of cytochrome c that is known to
control interactions between early pro-apoptotic signaling molecules (e.g., Apaf-1, caspase-9)
that are responsible for activation of a cascade of caspases [48]. Previously we have shown
that CD causes activation of a caspase cascade early during apoptosis [8]. However, the
mechanisms causing the late-stage nuclear alterations in CD-apoptosis are not well understood.
Interestingly, when HeLa cells were treated with UV, cytochrome c release and accumulation
in the nucleus correlated temporally with release of acetylated histone H2A into the cytosol
and chromatin condensation in cells undergoing apoptosis [49]. Our data are consistent with
this report and suggest that nuclear localization of cytochrome c may play a role in the end-
stage nuclear changes associated with CD-apoptosis. Importantly, we demonstrate that
stimulation with EGF prevents early (e.g., ΔΨm, cytochrome c release and nuclear
translocation) and late manifestations of CD-apoptosis (i.e., PARP cleavage, TUNEL).
We have evidence that EGF stimulation of a cell survival response in CD cells involves PI3
kinase-dependent activation of Akt and restoration of mitochondrial function. Indeed, the
restoration of mitochondrial ΔΨm and prevention of cytochrome c release and nuclear
translocation observed in EGF-treated CD cells was abolished by LY294002, a known inhibitor
or PI3 kinase [50]. Following activation, PI3 kinase phosphorylates Akt at Ser473, leading to
the phosphorylation of Akt substrates that could play a role in EGF stimulation of a cell survival
response in CD cells. Studies in quiescent non-hepatocyte type cells have shown that PI3
kinase/Akt-dependent phosphorylation and inactivation of Forkhead transcription factors (e.g.,
FKHR, AFX) contributes to increased incorporation of BrdU that is abolished by LY294002
[51]. Accordingly, we investigated whether changes in the activation of Forkhead transcription
factors could underlie the EGF cell survival response in CD cells. However, we found no effect
of EGF on the levels of activated or total FKHR and AFX in CT or CD cells. In addition, while
Akt473 is capable of phosphorylating Bad at Ser136, which is responsible for preventing
cytochrome c release and the activation of early apoptosis signaling molecules [52],
phosphorylated BadSer136 was not detected in CT or CD cells either in the absence or presence
of EGF stimulation. Nonetheless, LY294002 abolished EGF restoration of mitochondrial
functions. Thus further studies are required to better understand the role of PI3 kinase/Akt in
EGF rescue of CD-apoptosis.
In summary, we found that CD decreases the sensitivity of EGF receptors to EGF-induced
receptor tyrosine phosphorylation and induces a form of apoptosis in rat hepatocytes that is
mediated by dissipation of mitochondrial ΔΨm and release and nuclear translocation of
cytochrome c. CD-apoptosis was prevented by stimulation with EGF, and this action is
mediated by PI3 kinase/Akt-dependent restoration of ΔΨm and prevention of mitochondrial
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release and nuclear translocation of cytochrome c. Our studies provide novel insights on the
mechanism of CD-apoptosis, and suggest that restoration of mitochondrial functions plays a
more important role than restoration of choline metabolites in EGF-stimulation of a cell
survival response.
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Epidermal growth factor rescues p53-defective CWSV-1 cells from apoptosis induced by acute
withdrawal of choline. CWSV-1 hepatocytes in the log phase of growth were switched for 2
days to RPMI medium containing 70 μmol choline (CT) or 5 μmol choline (CD) with or without
epidermal growth factor (EGF) as described in the Materials and Methods. The occurrence of
apoptosis was determined by (A) PARP cleavage and (B) a TUNEL assay for apoptosis-
associated DNA fragmentation. Mean ± SE, n = 6/point; bars identified with different letters
are significantly different from one another (p < 0.01, t-test).
Albright et al. Page 11














Effects of choline availability and EGF on mitochondrial function. Mitochondrial
transmembrane potential (ΔΨm) was studied as described in the Materials and Methods with
the potential-sensitive probe CMX-Ros (red fluorescence) and the nuclear counterstain DAPI
(blue fluorescence). Compared to CWSV-1 cells maintained in control medium (70 μmol
choline) (A) cells maintained in choline deficient medium (5 μmol choline) exhibited decreased
incorporation of CMX-Ros consistent with disruption of ΔΨm (C). Treatment with EGF (10ng/
mL) for 48 hr restored MPT in CWSV-1 cells maintained in control (B) and choline deficient
medium (D). The relative levels of CMX-Ros (E) were measured using an objective image
analysis method as described in the Materials and Methods. In the absence of EGF, cells
maintained in control medium (white bars) exhibited a 3-fold increase in the amount of CMX-
Ros incorporated compared to cells in choline deficient medium (black bars). Treatment with
EGF (10 ng/mL x 48hr) restored the level of incorporation of CMX-Ros in choline deficient
cells to control levels. Consistent with restoration of ΔΨm. Mean ± SE, n = 4/treatment group;
columns identified with different letters differ significantly from one another (p < 0.01, t-test).
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Effects of choline availability and epidermal growth factor on cytochrome c release. CWSV-1
cells were grown and treated as described in Materials and Methods. Cells were fixed in
formaldehyde and immunocytochemically stained for cytochrome c (red). The cells were
visualized on a Nikon FX microscope and images captured by a digital camera. (A, B)
Localization of cytochrome c staining in CT cells (70 μmol choline) grown in the absence (A)
or presence (B) of EGF (10 ng/mL x 48 hrs). (C, D) Localization of cytochrome c staining in
CD cells grown in the absence (C) or presence (D) of EGF. In the absence of EGF, CD cells
exhibited a diffuse and cytoplasmic and nuclear pattern of cytochrome c staining, unlike the
punctate perinuclear staining of cytochrome c in CT cells. Treatment with EGF (10 ng/mL x
48 hr) restored the punctate perinuclear pattern of cytochrome c staining in CD cells maintained
in choline deficient medium (D) consistent with the pattern of staining observed in CT cells
(B). (E) Cytochrome c levels in total cell lysates were unaffected by choline availability or
EGF. Arrows: location of cytoplasm overlying nucleus.
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Epidermal growth factor restores cell proliferation in CD-CWSV-1 cells. Cells in the log phase
of growth were switched for an additional 2 days to control (70 μmol choline) or CD medium
(5 μmol choline) with or without EGF, and the percentage of cells incorporating BrdU (BrdU
labeling index) was determined as described in the Materials and Methods. Mean ± SE;
columns identified with different letters differ significantly from one another (p < 0.01,
ANOVA/Sheffe’s test).
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Effects of choline availability on EGF receptor tyrosine phosphorylation. CWSV-1 cells were
treated with EGF (0–300 ng/mL x 5 min) and the levels of tyrosine phosphorylation of EGF
(EGF pTyr) was assayed immunoblotting with anti-phosphotyrosine antibody (RC-20) and
quantified by densitometry, as described in the Materials and Methods. Hsp90 was used to
normalize band intensities for protein loading. The arrow indicates the EGF pTyr band at ~
170 kDa.
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Effects of choline availability and activation of PI3 kinase on the expression of Akt. CWSV-1
cells were treated with EGF (10 ng/mL x 5 min) in the absence or presence of LY294002 and
the levels of phosphorylated Akt and total Akt were assayed by immunoblotting with anti-
Akt473 and total Akt antibodies, as described in the Materials and Methods. Treatment with
EGF increased AktSer473 in CD medium (5 μM choline) cells more than in cells maintained
in control medium (70 μM choline). Treatment with the LY294002 (50 μM) either
simultaneous with (Ly+EGF) or for 1 hr before the addition of EGF (Ly/EGF) suppressed the
expression of Akt, consistent with PI3 kinase-dependent activation of AktSer473 in response
to EGF.
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Effects of choline availability and EGF on the expression of Forkhead-related transcription
factors. CWSV-1 cells were treated with EGF (10 ng/mL x 5 min) and the levels of
phosphorylated and total FKHR and AFX were assayed by immunoblotting with antibodies
that recognize FKHRSer256, total FKHR, AFXSer193, and total AFX., as described in the
Materials and Methods. Cells in control (CT) and choline deficient medium (CD) exhibited
similar levels of FKHR and AFX and treatment with EGF had no effect on the expression of
phosphorylated (inactivated) or total Forkhead-related proteins.
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Model for EGF-induced rescue against CD apoptosis in rat hepatocytes. Cells switched acutely
to CD medium (1) exhibit decreased sensitivity to EGF-induced receptor tyrosine
phosphorylation (2), and (3) proapoptotic mitochondrial alterations (i.e., loss of ΔΨm,
cytochrome c release, increased generation of ROS) that result in (4) activation of a caspases
cascade, (5) cleavage of PARP, and (6) the completion of apoptosis. In the presence of added
EGF (7), CD cells exhibit (8) PI3 kinase-dependent activation of AktSer473 (9), and (10)
restoration of early mitochondrial pro-apoptotic alterations (i.e., ΔΨm, cytochrome c),
independent of the expression of Forkhead-related proteins (i.e., FKHR, AFX) and
phosphorylated Bad.
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Table 1
Effects of choline and epidermal growth factor (EGF) on choline metabolites in CWSV-1 hepatocytes. CWSV-1 cells were grown
in control (CT, 70 μmol choline) or choline deficient (CD, 5 μmol choline) medium for 2 days with or without EGF (10 ng/mL),
and biochemical parameters measured as described in the Materials and Methods. Data are expressed as mean ± SE, n = 4/treatment
group; for each metabolite, data identified with different letters differ significantly (p < 0.01, ANOVA/Tukey-Kramer test). 1nmol/
mg DNA. GPCho = glycerophosphocholine; PCho = phosphocholine; PtdCho = phosphatidylcholine; SM = sphingomyelin.
CT CD
Metabolite1 (−) EOF (+) EGF (−) EGF (+) EGF
Choline 27.9 ± 2.0a 35.5 ± 8.1a 9.0 ± 0.9b 10.7 ± 1.6b
GPCho 129.2 ± 12.5a 133.4 ± 3.1a 106.8 ± 1.7b 92.4 ± 5.6b
PCho 619.5 ± 49.6a 534.8 ± 31.5b 61.4 ± 2.6c 53.4 ±2.1c
PtdCho 1680.2 ± 118.9a 1581.6 ± 54.9a,b 1443.8 ± 38.2b,c 1339.5± 53.8c
SM 210.8 ± 107.la 250.9 ± 23.8a 258.9 ± 25.9a 242.0 ± 17.8a
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